JB Chemicals and Pharma gets USFDA nod for hypertension tablets

New Delhi: JB Chemicals & Pharmaceuticals has received US health regulator's nod for Atenolol tablets, used in the treatment of high blood pressure.

"The United States Food and Drug Administration (USFDA) has approved the company's supplementary Abbreviated New Drug Application (ANDA) for Atenolol tablets USP 25mg, 50mg and 100 mg," JB Chemicals & Pharmaceuticals said in a BSE filing.

The company, which plans to commercialize this product in the next quarter, said the market for the approved product is about USD 70 million.

"The company is focused on US business and this approval will help the company grow its exports," it added.